مصراوي
مصراوي
Ready to play
Ready to play
A report has revealed that Egyptian consumption of pain relief medications reached approximately $195 million in 2025, with projections indicating an increase to $205 million in 2026. Sales could potentially reach $230 million by 2030 due to the ongoing demand for treatment of headaches, muscular pains, and joint discomfort. Pharmacies account for about 90% of these sales, dominated by five major companies. Oral medications constitute 85% of the market, thanks to their ease of use and widespread availability. The market's growth is linked to an increasing population and the expansion of digital sales channels, despite inflationary challenges that impact purchasing decisions.
Notice: This Is an AI-Generated Summary
Comments (0)